Literature DB >> 20830247

Monoclonal antibody Cam 5.2 targeted mainly CK8, but not CK18--Comment on: "Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation--report of a unique case. Int J Clin Exp Pathol. 2010 May 5; 3 (5):534-40.".

Chang Kuang Leei, Wea-Lung Lin, Chih-Ping Han.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20830247      PMCID: PMC2933396     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


× No keyword cloud information.
  2 in total

1.  Monoclonal antibody to cytokeratin for use in routine histopathology.

Authors:  C A Makin; L G Bobrow; W F Bodmer
Journal:  J Clin Pathol       Date:  1984-09       Impact factor: 3.411

2.  Chromophobe renal cell carcinoma with liposarcomatous dedifferentiation - report of a unique case.

Authors:  Fredrik Petersson; Michal Michal; Marcello Franco; Ondrej Hes
Journal:  Int J Clin Exp Pathol       Date:  2010-05-05
  2 in total
  3 in total

1.  A Strong Neutrophil Elastase Proteolytic Fingerprint Marks the Carcinoma Tumor Proteome.

Authors:  Michał Kistowski; Janusz Dębski; Jakub Karczmarski; Agnieszka Paziewska; Jacek Olędzki; Michał Mikula; Jerzy Ostrowski; Michał Dadlez
Journal:  Mol Cell Proteomics       Date:  2016-12-07       Impact factor: 5.911

2.  Inosine triphosphate pyrophosphohydrolase (ITPA) polymorphic sequence variants in Chinese ALL children and possible association with mercaptopurine related toxicity.

Authors:  Xiaoli Ma; Jie Zheng; Mei Jin; Weijing Li; Chao Gao; Dawei Zhang; Yiqiao Chen; Xingjun Li; Jianjun Xie
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

3.  High expression of cytokeratin CAM5.2 in esophageal squamous cell carcinoma is associated with poor prognosis.

Authors:  Shujin He; Jie Peng; Lei Li; Ying Xu; Xiaoxiao Wu; Juan Yu; Jianli Liu; Jinguo Zhang; Renya Zhang; Wei Wang
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.